News and Press Releases

How AI Is Changing NGS Workflows

Accent Therapeutics to Utilize Inocras’ CancerVision™ and MRDVision™ Platforms in Phase 1/2 ATX-295 Clinical Study

Powering Precision Oncology with Whole-Genome Insights

A Look Ahead: Predictions for the Life Sciences in 2026

Inocras: Interview With CEO Jehee Suh About The Bioinformatics-Led Whole Genome Insights Company

Inocras, Samsung Medical Center and Seoul St. Mary’s Hospital Researchers Publish Groundbreaking Study with 1,364 Whole-Genomes of Breast Cancer in Nature

STREAM Consortium and Inocras Unveil Landmark National Pediatric Cancer WGS Program, funded by the Lee Kun-hee Child Cancer and Rare Disease Project

Inocras Expands WGS-Based Cancer Precision Diagnostics CancerVision to 10 Hospitals

ChiMei Medical Center Adopts Inocras MRDVision and WGS Bioinformatics Platform for Precision Oncology in Taiwan

Inocras Unveils New MRDVision Data, Demonstrating Industry-leading Sensitivity in Head-to-Head Clinical Study Against Leading MRD NGS Assay